Medicare Enrolled
Dr. Biju Mathews, MD
Interventional Cardiology · Titusville, FL
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mathews from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mathews? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mathews
Dr. Biju Mathews is an interventional cardiology in Titusville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Mathews performed 7,685 Medicare services across 6,000 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mathews received a total of $284,984 from 64 pharmaceutical and/or device companies across 970 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mathews is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 12% volume in FL$ $284,984 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,685
Medicare services
Top 12% in FL for interventional cardiology
6,000
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~404 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,223 | $84 | $140 |
| Electrocardiogram (EKG), 12-lead | 1,241 | $10 | $45 |
| Echocardiogram, transthoracic | 482 | $129 | $550 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 329 | $15 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 329 | $10 | $45 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 326 | $56 | $150 |
| Hospital follow-up visit, moderate complexity | 324 | $62 | $150 |
| Ultrasound of both sides of head and neck blood flow | 237 | $134 | $350 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 209 | $19 | $50 |
| Remote pacemaker/defibrillator monitoring, 90 days | 179 | $14 | $38 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 178 | $46 | $180 |
| Remote pacemaker monitoring, 90 days | 172 | $19 | $40 |
| New patient office visit (45-59 min) | 171 | $106 | $225 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 165 | $10 | $25 |
| Initial hospital admission, moderate complexity | 147 | $100 | $250 |
| Ultrasonic guidance for blood vessel access | 123 | $12 | $30 |
| Prothrombin time test (blood clotting) | 113 | $4 | $21 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 92 | $15 | $35 |
| Programming of dual lead pacemaker system | 90 | $23 | $68 |
| Ultrasound of leg arteries or artery grafts | 65 | $172 | $350 |
| Cardiac catheterization | 59 | $215 | $745 |
| Coronary stent placement | 45 | $459 | $1,500 |
| EKG interpretation and report | 44 | $6 | $14 |
| Hospital follow-up visit, high complexity | 42 | $92 | $200 |
| Ultrasound of heart with probe in esophagus, with report | 31 | $83 | $200 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $14 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $2 | $5 |
| Initial hospital admission, high complexity | 29 | $137 | $300 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $292 | $850 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 22 | $58 | $225 |
| Programming of multiple lead implantable defibrillator system | 20 | $40 | $105 |
| Office visit, established patient, complex (40-54 min) | 18 | $96 | $213 |
| External shock to heart to regulate heart beat | 17 | $85 | $250 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 16 | $13 | $68 |
| Removal of plaque in arteries of leg | 14 | $456 | $1,500 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $263 | $810 |
| Review by radiologist of abdominal aorta image | 13 | $54 | $200 |
| Programming of single lead pacemaker system | 11 | $22 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $14 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.9% high complexity
17.4% medium
67.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$284,984
Total received (2018-2024)
Avg $40,712/year across 7 years
Top 2% in FL for interventional cardiology
64
Companies
970
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$249,151 (87.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,971 (10.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,862 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$8,846
2023$22,275
2022$97,383
2021$19,317
2020$19,768
2019$54,302
2018$63,093
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$87,360
Novo Nordisk Inc
$76,028
Boehringer Ingelheim Pharmaceuticals, Inc.
$63,729
Novartis Pharmaceuticals Corporation
$21,260
Medtronic Vascular, Inc.
$9,267
Lilly USA, LLC
$8,235
Penumbra, Inc.
$3,748
Medtronic, Inc.
$2,751
Abbott Laboratories
$1,357
ABIOMED
$1,337
GE HEALTHCARE
$1,142
Boston Scientific Corporation
$1,048
Amgen Inc.
$774
ShockWave Medical, Inc
$750
E.R. Squibb & Sons, L.L.C.
$730
Cardiovascular Systems Inc.
$570
SANOFI-AVENTIS U.S. LLC
$527
Merck Sharp & Dohme LLC
$471
PFIZER INC.
$386
AstraZeneca Pharmaceuticals LP
$342
Amarin Pharma Inc.
$301
W. L. Gore & Associates, Inc.
$278
Impulse Dynamics (USA) Inc.
$200
CARDIVA MEDICAL, INC.
$200
CVRx, Inc.
$188
Merck Sharp & Dohme Corporation
$173
Biosense Webster, Inc.
$151
Kowa Pharmaceuticals America, Inc.
$148
Esperion Therapeutics, Inc.
$133
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$125
ARBOR PHARMACEUTICALS, INC.
$114
ACIST MEDICAL SYSTEMS, INC.
$81
Bayer HealthCare Pharmaceuticals Inc.
$75
Gilead Sciences, Inc.
$74
Philips Electronics North America Corporation
$71
Bayer Healthcare Pharmaceuticals Inc.
$67
Braemar Manufacturing, LLC
$65
BIOTRONIK INC.
$61
Kestra Medical Technology Services, Inc.
$54
Lexicon Pharmaceuticals, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$46
AngioDynamics, Inc.
$41
Allergan Inc.
$37
BOSTON SCIENTIFIC CORPORATION
$37
Chiesi USA, Inc.
$35
Amryt Pharma Holdings Ltd
$35
CORDIS US CORP.
$28
LivaNova USA, Inc.
$26
Arbor Pharmaceuticals, Inc.
$24
Edwards Lifesciences Corporation
$20
iRhythm Technologies, Inc.
$20
Cook Medical LLC
$19
Teleflex LLC
$19
Aegerion Pharmaceuticals, Inc.
$19
Relypsa, Inc.
$18
Janssen Scientific Affairs, LLC
$18
Astellas Pharma US Inc
$18
ARALEZ PHARMACEUTICALS US INC.
$18
Avinger Inc.
$16
Daiichi Sankyo Inc.
$15
SCPHARMACEUTICALS INC.
$14
Terumo Medical Corporation
$14
ATRICURE, INC.
$13
BRACCO DIAGNOSTICS INC.
$13
Top 3 companies account for 79.7% of total payments
Associated products mentioned in payments ›
(9267) AngioSculpt CV RX · ACCOLADE SR · ANDEXXA · ANGIO-SEAL · ANGIOJET · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Assure WCD · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · CADUET · CAMZYOS · CARDIOGEN · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COREVALVE EVOLUT R · CVI SYSTEMS · Cardiac Monitoring Suite · Claria MRI · Cobalt · Cook Celect · CoreValve Evolut · Corlanor · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · ELIQUIS · EMBOSHIELD NAV6 · ENTRESTO · EXCLUDER Iliac Branch Endoprosthesis · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EverFlex · FARXIGA · FUROSCIX · GENERAL STENTS · GORE VIABAHN Endoprosthesis with Heparin · HAWKONE · HawkOne · IGT D Peripheral · IGT_D Peripheral · IN.PACT Admiral · INJECTAFER · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JUXTAPID · KENGREAL · Kerendia · LEQVIO · LEXISCAN · Launcher · LifeVest · Livalo · MICRA · MITRACLIP · MOUNJARO · MULTAQ · MYNX CONTROL · Manta · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NO PRODUCT DISCUSSED · OPTIMIZER · OPTIS · Optimizer · Ozempic · PACEART SYSTEM ECG MODULE · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · ProtekDuo · ProtekDuo Kit · RESOLUTE ONYX · REVEAL LINQ · RXI CONSUMABLES · RXI SYSTEMS · Repatha · Resolute · Reveal LINQ · Rybelsus · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Smart Coil · VENACURE 1470 PRO · VENASEAL · VERQUVO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · VIABAHN VBX Balloon Expandable Endoprosthesis · VIATORR Endoprosthesis · VIGILANT X4 CRT-D · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · XACT · XARELTO · XIENCE SIERRA · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for interventional cardiology in FL.
Equivalent to $3,708 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
4
Per 100K population
0.6
County median income
$75,817
Nearest hospital
PARRISH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mathews is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 12% in FL), and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mathews experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mathews performed 2,223 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mathews receive payments from pharmaceutical companies?
Yes. Dr. Mathews received a total of $284,984 from 64 companies across 970 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mathews's costs compare to other interventional cardiologys in Titusville?
Dr. Mathews's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mathews) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Titusville
Browse interventional cardiologys in Titusville ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology